ARRY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Array BioPharma Inc's account receivable for the three months ended in Jun. 2015 was $6.31 Mil. Array BioPharma Inc's revenue for the three months ended in Jun. 2015 was $12.32 Mil. Hence, Array BioPharma Inc's days sales outstanding for the three months ended in Jun. 2015 was 46.71.
Array BioPharma Inc's days sales outstanding declined from Jun. 2014 (82.41) to Jun. 2015 (46.71).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
Array BioPharma Inc's Days Sales Outstanding for the fiscal year that ended in Jun. 2015 is calculated as
Array BioPharma Inc's Days Sales Outstanding for the quarter that ended in Jun. 2015 is calculated as:
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Array BioPharma Inc Annual Data
Array BioPharma Inc Quarterly Data